Aging and bone loss: new insights for the clinician

被引:415
作者
Demontiero, Oddom [2 ]
Vidal, Christopher [2 ]
Duque, Gustavo [1 ]
机构
[1] Nepean Hosp, Nepean Clin Sch, Level 5,South Block, Penrith, NSW 2750, Australia
[2] Univ Sydney, Sydney Med Sch Nepean, Ageing Bone Res Program, Penrith, NSW, Australia
基金
英国医学研究理事会;
关键词
osteoporosis; aging; elderly; osteoblast; osteoclast; treatment;
D O I
10.1177/1759720X11430858
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
It is well known that the underlying mechanisms of osteoporosis in older adults are different than those associated with estrogen deprivation. Age-related bone loss involves a gradual and progressive decline, which is also seen in men. Markedly increased bone resorption leads to the initial fall in bone mineral density. With increasing age, there is also a significant reduction in bone formation. This is mostly due to a shift from osteoblastogenesis to predominant adipogenesis in the bone marrow, which also has a lipotoxic effect that affects matrix formation and mineralization. We review new evidence on the pathophysiology of age-related bone loss with emphasis upon the mechanism of action of current osteoporosis treatments. New potential treatments are also considered, including therapeutic approaches to osteoporosis in the elderly that focus on the pathophysiology and potential reversal of adipogenic shift in bone.
引用
收藏
页码:61 / 76
页数:16
相关论文
共 150 条
[1]
Adachi JD, 2001, ARTHRITIS RHEUM, V44, P202, DOI 10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO
[2]
2-W
[3]
Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts [J].
Akune, T ;
Ogata, N ;
Hoshi, K ;
Kubota, N ;
Terauchi, Y ;
Tobe, K ;
Takagi, H ;
Azuma, Y ;
Kadowaki, T ;
Nakamura, K ;
Kawaguchi, H .
JOURNAL OF CELL BIOLOGY, 2002, 159 (01) :147-156
[4]
High serum IGFBP-2 is predictive of increased bone turnover in aging men and women [J].
Amin, Shreyasee ;
Riggs, B. Lawrence ;
Melton, L. Joseph, III ;
Achenbach, Sara J. ;
Atkinson, Elizabeth J. ;
Khosla, Sundeep .
JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (06) :799-807
[5]
Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response [J].
Atkins, G. J. ;
Welldon, K. J. ;
Halbout, P. ;
Findlay, D. M. .
OSTEOPOROSIS INTERNATIONAL, 2009, 20 (04) :653-664
[6]
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease [J].
Balemans, W ;
Patel, N ;
Ebeling, M ;
Van Hul, E ;
Wuyts, W ;
Lacza, C ;
Dioszegi, M ;
Dikkers, FG ;
Hildering, P ;
Willems, PJ ;
Verheij, JBGM ;
Lindpaintner, K ;
Vickery, B ;
Foernzler, D ;
Van Hul, W .
JOURNAL OF MEDICAL GENETICS, 2002, 39 (02) :91-97
[7]
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) [J].
Balemans, W ;
Ebeling, M ;
Patel, N ;
Van Hul, E ;
Olson, P ;
Dioszegi, M ;
Lacza, C ;
Wuyts, W ;
Van den Ende, J ;
Willems, P ;
Paes-Alves, AF ;
Hill, S ;
Bueno, M ;
Ramos, FJ ;
Tacconi, P ;
Dikkers, FG ;
Stratakis, C ;
Lindpaintner, K ;
Vickery, B ;
Foernzler, D ;
Van Hul, W .
HUMAN MOLECULAR GENETICS, 2001, 10 (05) :537-543
[8]
In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation [J].
Baron, R ;
Tsouderos, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 450 (01) :11-17
[9]
Another Selective Estrogen-Receptor Modulator for Osteoporosis [J].
Becker, Carolyn .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (08) :752-754
[10]
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [J].
Black, Dennis M. ;
Delmas, Pierre D. ;
Eastell, Richard ;
Reid, Ian R. ;
Boonen, Steven ;
Cauley, Jane A. ;
Cosman, Felicia ;
Lakatos, Peter ;
Leung, Ping Chung ;
Man, Zulema ;
Mautalen, Carlos ;
Mesenbrink, Peter ;
Hu, Huilin ;
Caminis, John ;
Tong, Karen ;
Rosario-Jansen, Theresa ;
Krasnow, Joel ;
Hue, Trisha F. ;
Sellmeyer, Deborah ;
Eriksen, Erik Fink ;
Cummings, Steven R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) :1809-1822